5 Value Stocks With Attractive EV-to-EBITDA Ratios to Scoop Up

The article is a stock-screening piece highlighting five companies that passed a value screen based on low EV-to-EBITDA, P/E, P/B, and P/S multiples plus positive earnings growth and favorable Zacks ranks. Featured names include Genesco, Pampa Energia, Occidental Petroleum, Chatham Lodging Trust, and Transportadora de Gas del Sur, with expected 2026 or fiscal-year earnings growth ranging from 21.9% to 162.0%. This is informational rather than company-specific news, so the likely market impact is limited.

Analysis

The screen is effectively a quality filter masquerading as value: the names that pass are not deep cyclical wrecks, but balance-sheet-supported assets with visible earnings revisions. That matters because in a market where the cost of capital is still elevated, low EV/EBITDA is only durable when the numerator is not artificially suppressed by transient margin pressure; the strongest setups are where consensus is already inflecting higher, not simply where multiples are optically cheap.

Second-order, the list clusters around two themes that can re-rate faster than the market expects: energy cash-flow leverage and asset-heavy businesses with operating leverage to normalization. In energy and midstream, a modest improvement in commodity or throughput assumptions can translate into outsized equity upside because enterprise value already captures debt; in retail and lodging, the upside is more dependent on margin stabilization than topline growth, which makes them more vulnerable to a single bad comp or consumer-demand shock. That asymmetry argues for favoring names with estimate momentum over names that are merely statistically cheap.

The main risk is that EV/EBITDA can become a value trap when EBITDA is near peak or when the market is about to repriced debt more aggressively than earnings. For the more economically sensitive names, the next 1-2 quarters are the critical window: if estimate revisions stall, the apparent discount can widen before it mean-reverts. In contrast, where revisions are still moving up, the catalyst path is longer and more durable, especially over the next 6-12 months.

Consensus is likely underestimating how much the market rewards scarcity of clean earnings growth in a mediocre macro backdrop. The better trade is not simply buying the lowest multiple; it is buying the lowest multiple with positive revision momentum and hedging away the weakest demand beta. That makes the energy-heavy names structurally more interesting than the retail/REIT names, even if the latter look cheaper on static screens.

Key Decisions for Investors

• Go long OXY vs. short a consumer-sensitive value basket for 3-6 months: OXY has the cleanest combination of revision momentum and balance-sheet embedded optionality; the short leg should protect against a weak-demand tape that would hurt lower-quality value names first.
• Initiate a tactical long PAM/TGS pair with a 6-9 month horizon: both benefit from improving expectations, but TGS offers the cleaner defensive midstream profile while PAM carries higher operating and country-risk beta; use TGS as the lower-volatility anchor.
• Buy call spreads in OXY out 3-6 months rather than outright equity: this captures upside from continued estimate upgrades while limiting drawdown if crude fades or macro risk premium compresses.
• Avoid chasing CLDT as a standalone deep-value long unless you can hedge lodging beta: the setup is most vulnerable to any slowdown in RevPAR or funding conditions, and low EV/EBITDA can rerate lower if EBITDA plateaus.
• For GCO, wait for a post-earnings entry only if revisions hold: the name is best treated as a catalyst trade over 1-2 quarters, not a long-duration compounder; the risk/reward improves materially on confirmation of continued estimate upgrades.